XEPI

PeakSM

ozenoxacin

NDATOPICALCREAM
Approved
Dec 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
3

Clinical Trials (3)

NCT02229539Phase 3Completed

Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy

Started Nov 2014
275 enrolled
Acute Oral Mucositis Pain
NCT01156142Phase 3Completed

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Started Dec 2010
155 enrolled
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
NCT00755495Phase 2Completed

Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia

Started Jul 2006
472 enrolled
Sleep Initiation and Maintenance Disorders

Loss of Exclusivity

LOE Date
Jan 29, 2032
71 months away
Patent Expiry
Jan 29, 2032

Patent Records (2)

Patent #ExpiryTypeUse Code
9399014
Dec 15, 2029
U-805
9180200
Jan 29, 2032
Product
U-805